US Food and Drug Administration Statement on Boston Scientific/Guidant Pacemakers and Defibrillators
The statement made by US FDA in July 2006 promoting Boston Scientific/Guidant’s recommendation for the doctors to perform follow-up exams of patients with implanted defibrillators

FDA Nationwide Notification of Recall of Certain Guidant Defibrillators
FDA released an announcement in June2005 about Guidant Corporation’s recall of some implantable defibrillators and cardiac resynchronization therapy defibrillators

Guidant Corporation: Patient Communications Providing Important Safety Information
Information and letters to patients from Guidant Corporation about the safety of its defibrillators

ICD and Pacemaker Recalls: Do You Need a New Device?
Tips for patients given by John Hopkins Medical Letter and Guidant Corp

Boston Scientific: Patient Education
Information and resources for patients provided by Guidant’s parent company